Tyra Biosciences, Inc.
TYRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $570 | $552 | $818 |
| - Cash | $62 | $98 | $101 | $92 |
| + Debt | $5 | $6 | $6 | $6 |
| Enterprise Value | – | $477 | $457 | $733 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$30 | -$31 | -$32 | -$30 |
| % Margin | – | – | – | – |
| Net Income | -$30 | -$28 | -$28 | -$26 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.5 | -0.47 | -0.47 | -0.43 |
| % Growth | -6.4% | 0% | -9.3% | – |
| Operating Cash Flow | -$22 | -$24 | -$25 | -$20 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$22 | -$24 | -$25 | -$20 |